|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-6-22
|
|
pubmed:abstractText |
Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death worldwide. The insulin-like growth factors (IGFs) system consists of a group of proteins which may induce cell proliferation and inhibit cell apoptosis through several signal pathways, leading to transformation of normal cells into cancer cells. However, the impact of genetic polymorphisms of the IGFs system on HCC has not been clarified.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/IGFBP3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor II,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 2,
http://linkedlifedata.com/resource/pubmed/chemical/Somatomedins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
pubmed-author:ChenMu-KuanMK,
pubmed-author:ChenYi-ChenYC,
pubmed-author:ChuYin-HungYH,
pubmed-author:HsiehYi-HsienYH,
pubmed-author:LiuYu-FanYF,
pubmed-author:SuShih-ChiSC,
pubmed-author:TsaiChiung-ManCM,
pubmed-author:UengKwo-ChangKC,
pubmed-author:WengChia-JuiCJ,
pubmed-author:YangShun-FaSF,
pubmed-author:YehYuan-HungYH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1808-15
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20119675-Aged,
pubmed-meshheading:20119675-Carcinoma, Hepatocellular,
pubmed-meshheading:20119675-Case-Control Studies,
pubmed-meshheading:20119675-Female,
pubmed-meshheading:20119675-Genetic Predisposition to Disease,
pubmed-meshheading:20119675-Genotype,
pubmed-meshheading:20119675-Humans,
pubmed-meshheading:20119675-Insulin,
pubmed-meshheading:20119675-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:20119675-Insulin-Like Growth Factor Binding Proteins,
pubmed-meshheading:20119675-Insulin-Like Growth Factor I,
pubmed-meshheading:20119675-Insulin-Like Growth Factor II,
pubmed-meshheading:20119675-Liver Neoplasms,
pubmed-meshheading:20119675-Male,
pubmed-meshheading:20119675-Middle Aged,
pubmed-meshheading:20119675-Polymerase Chain Reaction,
pubmed-meshheading:20119675-Polymorphism, Genetic,
pubmed-meshheading:20119675-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:20119675-Receptor, IGF Type 1,
pubmed-meshheading:20119675-Receptor, IGF Type 2,
pubmed-meshheading:20119675-Risk Factors,
pubmed-meshheading:20119675-Somatomedins
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
|
|
pubmed:affiliation |
Tainan University of Technology, Tainan, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
